Antigen Receptors & Lymphocyte Development – Comprehensive Notes

Page 1

Reading Assignments & Context

  • Abbas et al. Chapters & pages: 2 (pp. 21–32), 5 (pp. 103–116), 8 (pp. 187–215), 10 (p. 248), 15 (pp. 346–347).
  • Instructor: Kaushlendra Tripathi, MS, PhD (VCOM-Carolinas).
  • Course: Immunology Block 1, Class 12 – Antigen Receptors and Lymphocyte Development (08 Aug 2025).

Page 2

Learning Objectives

  1. Define antigen receptors and describe their structure.
  2. Explain receptor roles in antigen recognition & lymphocyte development.
  3. Outline genetic organization of receptor loci.
  4. Trace mechanisms that generate receptor diversity; explain its immunologic value.
  5. Define:
    • Complementarity Determining Regions (CDRs)
    • Combinatorial Diversity
    • Junctional Diversity
    • Recombinase-Activating Gene (RAG) proteins
  6. Identify origins of immature lymphocytes.
  7. Sequence and interpret T-cell maturation & selection steps.
  8. Define: germline configuration, double-negative (DN), double-positive (DP), single-positive (SP) T cells; link to thymic anatomy.
  9. Sequence & interpret B-cell maturation & selection steps.
  10. Define receptor editing & affinity maturation; map their anatomic occurrences.
  11. Compare/contrast T- vs. B-cell maturation.
  12. Explain why selection preserves useful specificities.
  13. Predict immunologic consequences of failed maturation/selection.

Page 3

“What to Know” Checklist

  • B & T lymphocyte antigen receptors (BCR, TCR).
  • Antigens vs. epitopes.
  • Structural details of TCR & antibodies.
  • Generation of diverse repertoires.
  • Ig & TCR gene rearrangements; diversity sources.
  • Developmental pathways with anatomic sites & checkpoints.
  • Selection processes & clinical consequences of defects.

Page 4

Clinical Vignette (Review)

  • Female infant with recurrent infections, post-BCG lymphadenopathy, decreased T & B cells, normal NK cells.
  • Differential points: defects affecting both T & B (but not NK) → consider V(D)J recombination machinery.
  • Correct answer (later confirmed): E. Mutation in RAG1/RAG2 genes (Severe Combined Immunodeficiency, SCID).

Page 5

Antigen Recognition by Lymphocytes

  • Fact: Antigens bind immunoglobulins (Ig) & lymphocytes.
  • How? Via antigen receptors on B & T cells.
  • Definition: Lymphocyte antigen receptors = diverse membrane proteins capable of recognizing myriad foreign substances.

Page 6

Innate Immune “Vision”

  • Innate system detects:
    • PAMPs (Pathogen-Associated Molecular Patterns) – e.g., bacterial lipopolysaccharide; absent on mammalian cells; sensed by Pattern Recognition Receptors (PRRs).
    • DAMPs (Danger-Associated Molecular Patterns) – intracellular molecules released by damaged/necrotic host cells; recognized by PRRs.

Page 7

Adaptive Immune “Vision”

  • Antigens: virtually any molecule (proteins, glycoproteins, polysaccharides) recognized by adaptive immunity.
  • Receptors involved:
    • B-lymphocyte antibodies (BCR).
    • T-lymphocyte TCR.
  • Epitopes / Antigenic Determinants: specific sites within antigen that receptors bind.
    • Macromolecular antigens carry multiple different epitopes.
    • Conformational (discontinuous) vs. linear (continuous) epitopes.

Page 8

T-Cell Antigen Recognition

  • Majority of T cells recognize peptide–MHC complexes.
  • TCR: membrane protein that binds peptide presented by MHC (Class I or II).

Page 9

αβ T-Cell Receptor (TCR) Structure

  • Heterodimer: α and β transmembrane chains.
  • Each chain has:
    • Variable (V) domain – contains hypervariable regions = CDRs (antigen-contact).
    • Constant (C) domain.
  • αβ T cells ≈ 90 % of circulating T cells; include CD4⁺ helper & CD8⁺ cytotoxic subsets.
  • γδ TCR structurally similar but on minority γδ T cells.

Page 10

B-Cell Antigen Recognition

  • B cells “see” native antigens through antibody molecules anchored as BCR.

Page 11

Antibody (BCR) Structure

  • Tetramer: H<em>2L</em>2H<em>2L</em>2 (2 heavy, 2 light chains).
  • Light chains: κ or λ (one type per B cell).
  • Variable domains (VH, VL) contain CDRs that form antigen-binding site.
  • Five heavy-chain isotypes (IgM, IgD, IgG, IgA, IgE) differ in constant region (C_H) sequences → distinct effector functions.
    • Mature naïve B cells co-express IgM + IgD.
  • Membrane-bound form = BCR (has transmembrane segment on H chain).

Page 12

Secreted Antibody vs. Membrane Antibody

  • Secreted Ig: same V regions, soluble C_H tails.
  • Hinge region provides flexibility.
  • Fab (Fragment antigen-binding) – contains V regions.
  • Fc – C_H region; determines effector action (complement activation, FcR binding).

Page 13

Need for Genetic Economy → Gene Rearrangement

  • Genome lacks unique gene per receptor specificity.
  • V regions encoded by gene segments combined during lymphocyte development into complete exons.

Page 14–15

Domain Map of Ig & TCR Chains

  • Ig Light: V<em>LV<em>L | C</em>LC</em>L.
  • Ig Heavy: V<em>HV<em>H | C</em>H1C</em>{H1} C<em>H2C<em>{H2} C</em>H3C</em>{H3}.
  • TCR α: V<em>αV<em>α | C</em>αC</em>α.
  • TCR β: V<em>βV<em>β | C</em>βC</em>β.
  • Key: V regions assembled from multiple gene segments → diversity.

Page 16

Germline Organization & V(D)J Rearrangement

  • Loci contain numerous V, D (heavy or β only), J, and C segments.
  • Discovery: Susumu Tonegawa (Nobel) – proved somatic recombination.
  • Result: 107−10910^{7} - 10^{9} clones generated from limited genes.
  • Concept: V(D)J recombination randomly fuses one V + (optional) D + J.

Page 17

Mechanism Example: Ig Heavy Chain

  1. Germline: V–D–J segments separated.
  2. Rearrangement joins one V, one D, one J → contiguous VDJVDJ exon.
  3. Transcription → splicing with C region exons → mRNA.
  4. Translation → full μ heavy chain protein.
  • Process is antigen-independent.

Page 18

Ordered Rearrangements

  • B cells:
    • Heavy (V–D–J) first → μ chain.
    • Light (V–J) next (κ, then λ if needed).
  • T cells:
    • β chain (V–D–J) first.
    • α chain (V–J) next.
  • Rearrangement restricted to developing lymphocytes (lineage-specific).

Page 19–20

Enzymatic Machinery & RSS

  • Recombination Signal Sequences (RSS) flank V, D, J segments.
  • V(D)J recombinase complex:
    • Lymphoid-specific core = RAG-1 & RAG-2.
    • Ubiquitous DNA-repair factors (Ku, DNA-PKcs, ligase IV, Artemis, etc.).
  • Steps:
    1. RAGs bind RSS, synapse segments.
    2. Introduce double-strand breaks.
    3. Hairpin opening, processing, ligation → coding joint; signal joint excised.

Page 21

Combinatorial Diversity Sources

  1. Multiple germline segments – many V, D, J copies.
  2. Chain pairing – random heavy/light (or α/β) combinations.
    Potential combinations=(V<em>H×D</em>H×J<em>H)×(V</em>L×JL)\text{Potential combinations} = (V<em>H \times D</em>H \times J<em>H) \times (V</em>L \times J_L) for Ig; analogous for TCR.

Page 22

Junctional Diversity (adds greatest variability, esp. CDR3)

  1. Exonuclease trimming – random nucleotide loss at joints.
  2. N-region addition – Terminal deoxynucleotidyl transferase (TdT) adds random nucleotides.
  3. P-nucleotide addition – palindromic sequences from hairpin fill-in.
  • Generates non-templated sequence diversity; may create frameshifts (non-productive).

Page 23

Quantitative Diversity & Affinity Maturation

  • Theoretical repertoire: 1011−101610^{11} - 10^{16} specificities.
  • Real in vivo unique clones: 107−10910^{7} - 10^{9} simultaneously.
  • TCR specificity fixed post-rearrangement.
  • BCR specificity tunable after activation via Affinity Maturation (somatic hypermutation & selection in germinal centers).

Page 24

Hematopoiesis Overview

  • Hematopoietic Stem Cell → Common Lymphoid Progenitor (CLP) → lineage choice.
  • Bone marrow: site for B development; IL-7 drives Pro-B/T proliferation.
  • Thymus: site for T development; NK cells diverge from CLP without V(D)J.

Page 25–26

General Checkpoints

  1. Commitment & proliferation (growth-factor driven).
  2. Initiation of antigen receptor gene rearrangement (Pro-stage).
  3. Expression of pre-antigen receptor (Pre-stage) → signals survival/proliferation.
  4. Selection for functional, non-self-reactive receptors (Immature stage).
  5. Differentiation into mature subsets; exit to periphery.
  • Successful receptor synthesis dictates fate; defects cause arrest/apoptosis.

Page 27–29

Detailed B-Cell Development

  • Bone marrow sequence:
    1. Pro-B – heavy-chain D–J then V–DJ recombination.
    2. Pre-B – μ heavy chain + surrogate light chain (VpreB & λ5) forms pre-BCR.
      • Signals: stop further heavy rearrangement (allelic exclusion), initiate light κ rearrangement.
    3. If κ non-productive, attempt λ.
    4. Immature B – expresses membrane IgM only.
    5. Mature naïve B – IgM + IgD co-expression after alternative splicing; migrates to spleen/follicles.
  • Allelic exclusion ensures single specificity.

Page 30

Central B-Cell Tolerance

  • Occurs at immature stage in bone marrow.
  • Outcomes:
    • Strong self-antigen binding →
    – Receptor editing (new light-chain V–J rearrangement).
    – Deletion (apoptosis).
    • Weak self-antigen binding → Anergy (functional unresponsiveness).

Page 31

B-Lineage Markers & Summary

  • CD19, CD20 expressed throughout B development.
  • Flow cytometry utility.

Page 32–36

T-Cell Development Steps

  1. Pro-T (DN, CD4⁻CD8⁻) – TCR β D–J, then V–DJ rearrangement; IL-7-driven proliferation.
  2. Pre-T – β chain + invariant pre-Tα forms pre-TCR → signals:
    • stop β rearrangement (allelic exclusion).
    • start α V–J rearrangement.
    • induce CD4 & CD8 expression → Double Positive (DP).
  3. Selection in cortex:
    • Positive – moderate affinity for self-MHC ⇒ survival; lineage choice:
    – Class I MHC recognition → commit to CD8⁺.
    – Class II MHC recognition → commit to CD4⁺.
    • Negative – no recognition (death by neglect) OR high-affinity recognition (clonal deletion).
  4. Medullary selection (further negative selection vs tissue-restricted antigens presented by AIRE-expressing epithelial cells).
  5. SP mature T cells exit to periphery.

Page 35 Key Definitions

  • DN: Double-Negative (CD4⁻CD8⁻).
  • DP: Double-Positive (CD4⁺CD8⁺).
  • SP: Single-Positive (CD4⁺CD8⁻ or CD4⁻CD8⁺).

Page 37

Molecular/Phenotypic Timeline

  • RAG & TdT expression high during gene rearrangements; absent after maturation.
  • Surface markers: c-Kit (stem-cell factor receptor) high early; CD25 high in Pre-T.

Page 38

Regulatory T Cell (Treg) Development

  • Some self-reactive DP/SP thymocytes differentiate into CD4⁺CD25⁺FOXP3⁺ Tregs rather than deletion.
  • Function: Suppress autoimmunity; maintain tolerance.

Page 39

Unconventional T-Cell Subsets

  • iNKT: αβ TCR with invariant α chain; recognize lipid antigens on CD1d.
  • γδ T cells: recognize non-peptide antigens; abundant in epithelia.
  • MAIT: recognize vitamin-B-related metabolites presented by MR1 molecule; enriched in liver.

Page 40

Clinical Consequences of Developmental Failures

  • Combined defects (T + B) → Severe Combined Immunodeficiency (SCID) → susceptibility to bacterial, viral, fungal infections.
  • Isolated B-cell failure → antibody deficiency → bacterial infections predominance.

Page 41

Master Summary Statements

  1. TCR (membrane only) binds peptide–MHC.
  2. BCR (membrane Ig) binds a wide range of native antigens; antibodies can be secreted.
  3. Most T cells = αβ; antibodies = heavy + light chains.
  4. Enormous receptor diversity generated mainly by V(D)J recombination.
  5. Lymphocyte progenitors arise in bone marrow.
  6. B-cell gene rearrangements/selection in BM (receptor editing/deletion).
  7. T-cell rearrangements/selection in thymus (positive & negative).
  8. Mature lymphocytes populate periphery for immune defense.
  9. Developmental defects lead to immunodeficiencies.

Pages 42–45

Practice Questions (Key Take-Home Points)

  1. BCRs specific for a respiratory virus contain transmembrane forms of Ig heavy chains (correct answer: “Contain the transmembrane form of Ig heavy chains”).
    • Incorrect stems explained:
    – Bind epitopes with Fab, not hinge/Fc.
    – Class I MHC recognition is TCR-mediated.
    – Light chains are present & soluble in secreted antibodies.
  2. RAG-1 deficiency → lack of mature B & T lymphocytes; NK cells spared.

Page 46

Reprise of Clinical Vignette

  • Presentation mirrors RAG1/2 mutation SCID (answer E).
    • Both B & T low; NK normal.
    • History of severe infections post live BCG vaccine.

Page 47

Key References

  • Abbas, Lichtman, Pillai: Basic Immunology, 6th Ed (2019).
  • Abbas, Lichtman, Pillai: Cellular & Molecular Immunology, 9th Ed (2018).